
A small molecule NNMT inhibitor that preserves NAD+ levels and activates SIRT1 (the 'longevity gene'). Primarily taken orally - trending in longevity clinic protocols.
5-Amino-1MQ's fingerprint across categories
Report volume over 12 months
"5-Amino-1MQ helped me break through a fat loss plateau. Metabolism feels revved up. Taking it orally - easy protocol."
"Stacking 5-Amino-1MQ with NAD+ injections. The NNMT inhibition preserves what I'm putting in. Energy is consistently high."
"SIRT1 activation is the goal here. Longevity clinics are adding this to protocols. Feel more energetic daily."
Long-term human safety data still being established.
85% of community members report using this dosing protocol 1-2x daily. Individual responses vary — start low and adjust based on your experience.
5-Amino-1MQ inhibits NNMT, an enzyme that depletes NAD+. By blocking NNMT, it preserves NAD+ levels and activates SIRT1 for longevity benefits. Most users take it orally. Growing adoption in metabolic and longevity clinics.